FY25 pharma exports cross $30 bn, surge 31% in March, Pg13

Key Highlights

• FY25 total pharma exports: $30.47 billion
• YoY growth in March 2025: 31.21% (to $3.68 billion)
• FY24 exports: $27.85 billion
• Pharma share in exports: Rising, despite global uncertainties and tariff threats

Category-wise Breakdown

• Formulations & Biologics: $20.11 billion (highest share)
• Bulk drugs/intermediates: $4.31 billion
• Vaccines: $1.04 billion (↓4.2%)
• Surgicals: $683.47 million (↑5.16%)
• Ayush & Herbal: $620.97 million (↑6.17%)

Region-wise Analysis

• U.S.: Largest market, $8.95 billion (↑14.29%), >33% of India’s pharma exports
• Europe: $3.78 billion (↑7.53%)
• Africa: Slight decline (↓1.74%)
• North East Asia: Notable fall (↓4.30%)
• South Africa: Minor decline despite being a top market

Noteworthy Trends

• March 2025 saw highest monthly YoY growth: 31.21%
• Geopolitical uncertainties, U.S. tariff threat, and logistics issues didn't deter performance
• India was not listed in the U.S. reciprocal tariff list (26%) that President Trump announced (now on hold for 90 days)

Challenges Noted

• Top countries with decline in exports:
  • UAE (↓17.70%)
  • Turkey (↓16%)
  • Sri Lanka (↓14.60%)
  • Netherlands (↓13.79%)
  • China (↓10.60%)
  • Belgium (↓7.37%)
  • Only Mexico (↓3.80%) and Thailand (↓0.14%) saw relatively mild drops.

Significance

• Reflects the resilience of India’s pharma sector, despite global headwinds.
• India's pharmaceutical industry is a key pillar of soft power and trade strategy.
• Strengthens India’s position as the “Pharmacy of the World.”

Analysis & Way Forward

• Diversify export markets further to reduce dependence on U.S.
• Address logistics bottlenecks and bulk drug capacity building
• Incentivise vaccines and biotech to regain lost export ground
• Ensure proactive responses to global regulatory and tariff shocks

Mains Mock Question:

“India’s pharmaceutical exports have performed robustly even amidst global uncertainties. Examine the factors contributing to this resilience. What policy measures can enhance India’s status as the ‘pharmacy of the world’?”